Safety pharmacology during the COVID pandemic

Michael K. Pugsley*, Yevgeniya Koshman, Tessa de Korte, Simon Authier, Michael J. Curtis

*Corresponding author for this work

Research output: Contribution to journalEditorialpeer-review


This editorial summarizes the content of the current themed issue of J Pharmacol Toxicol Methods derived from the 2020 Annual Safety Pharmacology Society (SPS) meeting that was held virtually September 14–17, 2020 due to the ongoing COVID-19 global pandemic. A selection of articles arising from the virtual meeting is summarized. Like previous years they continue to reflect current areas of innovation in SP including new methodologies to predict human safety, best practices for IKr current measurement, and best practice considerations for the conduct of in vivo nonclinical QT studies. The meeting included scientific content from 94 abstracts (reproduced in the current volume of J Pharmacol Toxicol Methods). This continued innovation reflects a rubric in SP that identifies problems, seeks solutions and, importantly, validates the solutions.

Original languageEnglish
Article number107089
JournalJournal of pharmacological and toxicological methods
Publication statusPublished - 1 Sept 2021


Dive into the research topics of 'Safety pharmacology during the COVID pandemic'. Together they form a unique fingerprint.

Cite this